Skip to main content

Advertisement

SpringerLink
Log in

F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The extra domain A (ED A) of fibronectin has been identified as a tumor vessel specific neovascular marker in glioma. Antibody based vascular targeting against ED A of fibronectin allows precise accumulation of photosensitizer in glioma microvasculature and thereby promises to overcome drawbacks of current photodynamic therapy (PDT) for glioma treatment. Our aim was to characterize microcirculatory consequences of F8-small immunoprotein (SIP) mediated PDT by intravital microscopy (IVM) and to analyze the effects on glioma growth. For IVM SF126 glioma cells were implanted into dorsal skinfold-chamber of nude mice. PDT was performed after intravenous injection of photosensitizer (PS)-coupled F8-SIP or PBS (n = 4). IVM was performed before and after PDT for 4 days. Analysis included total and functional (TVD, FVD) vessel densities, perfusion index (PI), microvascular permeability and blood flow rate (Q). To assess tumor growth SF126 glioma cells were implanted subcutaneously. PDT was performed as a single and repetitive treatment after PS-F8-SIP injection (n = 5). Subcutaneous tumors were treated after uncoupled F8-SIP injection as control group (n = 5). PDT induced microvascular stasis and thrombosis with reduced FVD (24 h: 115.98 ± 0.7 vs. 200.8 ± 61.9 cm/cm2) and PI (39 ± 11 vs. 70 ± 10 %), whereas TVD was not altered (298 ± 39.2 vs. 278.2 ± 51 cm/cm2). Microvascular dysfunction recovered 4 days after treatment. Microvascular dysfunction led to a temporary reduction of glioma growth in the first 48 h after treatment with complete recovery 5 days after treatment. Repetitive PDT resulted in sustained reduction of tumor growth. F8-SIP mediated PDT leads to microvascular dysfunction and reduced glioma growth in a preclinical glioma model with recovery of microcirculation 4 days after treatment. Repetitive application of PDT overcomes microvascular recovery and leads to prolonged antiglioma effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tetard MC, Vermandel M, Mordon S, Lejeune JP, Reyns N (2014) Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid. Photodiagn Photodyn Ther 11(3):319–330. doi:10.1016/j.pdpdt.2014.04.004

    Article  CAS  Google Scholar 

  2. Tzerkovsky DA, Osharin VV, Istomin YP, Alexandrova EN, Vozmitel MA (2014) Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models. Exp oncol 36(2):85–89

    CAS  PubMed  Google Scholar 

  3. Zhan Q, Yue W, Shaoshan H (2011) The inhibitory effect of photodynamic therapy and of an anti-VCAM-1 monoclonal antibody on the in vivo growth of C6 glioma xenografts. Braz J Med Biol Res 44(5):489–490. doi:10.1590/S0100-879X2011007500052

    Article  CAS  PubMed  Google Scholar 

  4. Zhang X, Guo M, Shen L, Hu S (2014) Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model. Photodiagn Photodyn Ther 11(4):603–612. doi:10.1016/j.pdpdt.2014.10.007

    Article  CAS  Google Scholar 

  5. Casi G, Neri D (2012) Antibody-drug conjugates: basic concepts, examples and future perspectives. J Control Release 161(2):422–428

    Article  CAS  PubMed  Google Scholar 

  6. Rybak J-N, Roesli C, Kaspar M, Villa A, Neri D (2007) The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67(22):10948–10957

    Article  CAS  PubMed  Google Scholar 

  7. Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak J-N, Rösli C, Borsi L, Neri D (2008) A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Inte J cancer 122(11):2405–2413

    Article  CAS  Google Scholar 

  8. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K (1993) Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143(4):1055–1062

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Palumbo A, Hauler F, Dziunycz P, Schwager K, Soltermann A, Pretto F, Alonso C, Hofbauer GF, Boyle RW, Neri D (2011) A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels. Br J Cancer 104(7):1106–1115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Czabanka M, Vinci M, Heppner F, Ullrich A, Vajkoczy P (2009) Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy. Int J Cancer 124(6):1293–1300

    Article  CAS  PubMed  Google Scholar 

  11. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, Menger MD (1998) Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cerebral Blood Flow Metab 18(5):510–520

    Article  CAS  Google Scholar 

  12. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39(5):386–393. doi:10.1002/lsm.20507

    Article  PubMed  Google Scholar 

  13. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T, Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845–852. doi:10.3171/2013.7.JNS13415

    Article  CAS  PubMed  Google Scholar 

  14. Bhuvaneswari R, Yuen GY, Chee SK, Olivo M (2011) Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. Lasers Surg Med 43(7):651–662. doi:10.1002/lsm.21109

    Article  PubMed  Google Scholar 

  15. Chen B, Pogue BW, Hoopes PJ, Hasan T (2005) Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys 61(4):1216–1226. doi:10.1016/j.ijrobp.2004.08.006

    Article  CAS  PubMed  Google Scholar 

  16. Chen B, Pogue BW, Hoopes PJ, Hasan T (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16(4):279–305

    Article  PubMed  Google Scholar 

  17. Lawrence JE, Steele CJ, Rovin RA, Belton RJ Jr, Winn RJ (2015) Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells. J Neurooncol. doi:10.1007/s11060-015-2012-x

    Google Scholar 

  18. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ (2000) Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60(15):4066–4069

    CAS  PubMed  Google Scholar 

  19. Yi W, Xu HT, Tian DF, Wu LQ, Zhang SQ, Wang L, Ji BW, Zhu XN, Okechi H, Liu G, Chen QX (2015) Photodynamic therapy mediated by 5-aminolevulinic acid suppresses gliomas growth by decreasing the microvessels. J Huazhong Univ Sci Technol Med Sci 35(2):259–264. doi:10.1007/s11596-015-1421-6

    Article  CAS  PubMed  Google Scholar 

  20. Rybak J-N, Trachsel E, Scheuermann J, Neri D (2007) Ligand-based vascular targeting of disease. ChemMedChem 2(1):22–40

    Article  CAS  PubMed  Google Scholar 

  21. Czabanka M, Parmaksiz G, Bayerl SH, Nieminen M, Trachsel E, Menssen HD, Erber R, Neri D, Vajkoczy P (2011) Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies. Eur J Cancer 47(8):1276–1284

    Article  CAS  PubMed  Google Scholar 

  22. Gallagher-Colombo SM, Maas AL, Yuan M, Busch TM (2012) Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response. Isr J Chem 52(8–9):681–690. doi:10.1002/ijch.201200011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Muller PJ, Wilson BC (1986) An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys Med Biol 31(11):1295–1297

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded by the Immuno-PDT consortium and the Berliner Krebsgesellschaft e.V.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany

    G. Acker, P. Vajkoczy & M. Czabanka

  2. Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH, Zurich, Switzerland

    A. Palumbo & D. Neri

Authors
  1. G. Acker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Palumbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Neri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Vajkoczy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Czabanka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Vajkoczy.

Ethics declarations

Conflict of interest

H.D.M. was a senior director at Bayer Schering Pharma and owns few regular stocks from an employee stock purchase plan since February 2008. Dario Neri is a co-founder and shareholder of Philogen, the biotech company which has inlicensed the F8 antibody from ETH Zurich. The remaining authors declare no competing conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acker, G., Palumbo, A., Neri, D. et al. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth. J Neurooncol 129, 33–38 (2016). https://doi.org/10.1007/s11060-016-2143-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2143-8

Keywords

Search

Navigation